Anavex Life Sciences Reports Narrowed Annual Loss Despite Q4 Setback
Anavex Life Sciences narrows annual loss to $43 million despite a Q4 loss of $11.6 million. Stock down over 7% this year. Explore more on their financial performance.
Anavex Life Sciences reports a fiscal Q4 loss of $11.6 million, narrowing its annual loss to $43 million. Stock performance shows a decline of over 7% this year.